After receiving countless questions, the AIFA Medical Sales Representatives Office has decided to give clarification on Q&A 13, which is related to the disclosure of promotional materials (PM) to non-hospital pharmacists about prescription medicines in the 'Questions & Answers' document published on 3 May 2023 on the AIFA portal.

In particular, the document states that, with the exception of hospital pharmacists, advertising for prescription drugs may only be made by reproduction of the full summary of product characteristics (RCP). This restriction also applies to advertising material produced in accordance with the procedures provided for in paragraph 4 of art. 119 of Legislative Decree 219/2006.

As regards medicinal products sold without prescription, advertising is permitted and may include other documentation, provided that it complies with the provisions of Title VIII of the same Decree.

It is also noted that information of a purely commercial nature, such as price lists, are not subject to the discipline of Title VIII and may be disclosed without prior deposit with AIFA, as clarified in D&R 24.